0001144204-11-056641.txt : 20111005 0001144204-11-056641.hdr.sgml : 20111005 20111005215641 ACCESSION NUMBER: 0001144204-11-056641 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110927 FILED AS OF DATE: 20111005 DATE AS OF CHANGE: 20111005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bronfeld Zeev CENTRAL INDEX KEY: 0001298522 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50298 FILM NUMBER: 111128189 MAIL ADDRESS: STREET 1: 6 URI STREET CITY: TEL AVIV STATE: L3 ZIP: 64954 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001176309 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980376008 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 2 ELZA STREET CITY: JERUSALEM STATE: L3 ZIP: 93706 BUSINESS PHONE: 011 972-54-7909058 MAIL ADDRESS: STREET 1: 2 ELZA STREET CITY: JERUSALEM STATE: L3 ZIP: 93706 FORMER COMPANY: FORMER CONFORMED NAME: Integrated Security Technologies, Inc. DATE OF NAME CHANGE: 20040614 FORMER COMPANY: FORMER CONFORMED NAME: IGUANA VENTURES LTD DATE OF NAME CHANGE: 20020625 4/A 1 v236639_4a.xml OWNERSHIP DOCUMENT X0304 4/A 2011-09-27 2011-09-28 1 0001176309 ORAMED PHARMACEUTICALS INC. ORMP.OB 0001298522 Bronfeld Zeev 6 URI STREET TEL AVIV L3 64954 ISRAEL 0 0 1 0 Common Stock 2011-09-27 4 S 0 350000 0.28 D 5808517 D Common Stock 781250 I Via DNA Biomedical Solutions Ltd. D.N.A Biomedical Solutions Ltd. ("DNA") owns 781,250 shares of common stock of the Issuer ("Common Stock") and warrants exercisable for 273,438 shares of Common Stock. The Reporting Person holds 22.13% of DNA's outstanding share capital. The Reporting Person and Mr. Meni Mor are parties to a Voting Agreement relating to their shares of DNA, representing, in the aggregate, approximately 44.36% of DNA's outstanding share capital. As a result of the Voting Agreement, the Reporting Person may be deemed a beneficial owner of, and to share the power to vote and dispose, the Issuer securities held by DNA. The Reporting Person disclaims beneficial ownership of any of the Issuer securities held by DNA. The Form 4 is being amended to correct the percentages of DNA outstanding share capital owed by the Reporting Person and Mr. Mor referenced in this footnote. The Form 4 is also being amended to check the exit box is indicating that the Reporting Person is no longer subject to Section 16. /s/ Zeev Bronfeld 2011-10-05